Literature DB >> 15348442

Factors influencing the compressive strength of an injectable calcium sulfate-hydroxyapatite cement.

M Nilsson1, L Wielanek, J-S Wang, K E Tanner, L Lidgren.   

Abstract

A biphasic injectable bone substitute, suitable for filling bone defects, that sets in the body, based on calcium sulfate and hydroxyapatite (HA), is presented. For applications in bone defects the compressive strength is important to assure support of the defect site during loading when the patient is weight bearing. To control the strength, the influence of four different factors; the liquid-to-powder (L/P) ratio, the HA particle morphology, the HA content and the amount of accelerator, were investigated. alpha-Calcium sulfate hemihydrate (CSH) and four different HA powders (three sintered and one spray-dried) were used. All differed in size and morphology. CSH and each HA powder were mixed together with distilled water to form the bone substitute. An accelerator, in form of calcium sulfate dihydrate, was added to the powder phase to obtain an adequate setting time. Cylindrical specimens were compression tested. A lower L/P-ratio gave stronger cement, but was more difficult to inject. The shape and the morphology of the HA particles influenced the strength, and reducing the amount of HA increased the strength. The amount of accelerator (calcium sulfate dihydrate) had no influence.

Entities:  

Year:  2003        PMID: 15348442     DOI: 10.1023/a:1023254632704

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  12 in total

Review 1.  Clinical applications of bone graft substitutes.

Authors:  S N Khan; E Tomin; J M Lane
Journal:  Orthop Clin North Am       Date:  2000-07       Impact factor: 2.472

2.  The use of plaster of Paris to fill defects in bone.

Authors:  L F PELTIER
Journal:  Clin Orthop       Date:  1961

3.  The use of an injectable, biodegradable calcium phosphate bone substitute for the prophylactic augmentation of osteoporotic vertebrae and the management of vertebral compression fractures.

Authors:  B Bai; L M Jazrawi; F J Kummer; J M Spivak
Journal:  Spine (Phila Pa 1976)       Date:  1999-08-01       Impact factor: 3.468

4.  Influence of hydroxyapatite particle size on bone cell activities: an in vitro study.

Authors:  J S Sun; H C Liu; W H Chang; J Li; F H Lin; H C Tai
Journal:  J Biomed Mater Res       Date:  1998-03-05

5.  Skeletal repair by in situ formation of the mineral phase of bone.

Authors:  B R Constantz; I C Ison; M T Fulmer; R D Poser; S T Smith; M VanWagoner; J Ross; S A Goldstein; J B Jupiter; D I Rosenthal
Journal:  Science       Date:  1995-03-24       Impact factor: 47.728

6.  Osteogenic response of rabbit tibia to hydroxyapatite particle-Plaster of Paris mixture.

Authors:  S Sato; T Koshino; T Saito
Journal:  Biomaterials       Date:  1998-10       Impact factor: 12.479

7.  Experimental hydroxyapatite cement cranioplasty.

Authors:  P D Costantino; C D Friedman; K Jones; L C Chow; G A Sisson
Journal:  Plast Reconstr Surg       Date:  1992-08       Impact factor: 4.730

8.  Osteotransductive bone cements.

Authors:  F C Driessens; J A Planell; M G Boltong; I Khairoun; M P Ginebra
Journal:  Proc Inst Mech Eng H       Date:  1998       Impact factor: 1.617

9.  Bone formation in the presence of phagocytosable hydroxyapatite particles.

Authors:  J S Wang; S Goodman; P Aspenberg
Journal:  Clin Orthop Relat Res       Date:  1994-07       Impact factor: 4.176

10.  Regeneration of bone in the presence of calcium sulfate.

Authors:  A S Coetzee
Journal:  Arch Otolaryngol       Date:  1980-07
View more
  8 in total

1.  Preparation of hydroxyapatite/collagen injectable bone paste with an anti-washout property utilizing sodium alginate. Part 1: influences of excess supplementation of calcium compounds.

Authors:  Taira Sato; Masanori Kikuchi; Mamoru Aizawa
Journal:  J Mater Sci Mater Med       Date:  2017-02-08       Impact factor: 3.896

2.  Controllable release of salmon-calcitonin in injectable calcium phosphate cement modified by chitosan oligosaccharide and collagen polypeptide.

Authors:  D X Li; H S Fan; X D Zhu; Y F Tan; W Q Xiao; J Lu; Y M Xiao; J Y Chen; X D Zhang
Journal:  J Mater Sci Mater Med       Date:  2007-07-10       Impact factor: 3.896

3.  Cytotoxic Effects and Osteogenic Activity of Calcium Sulfate with and without Recombinant Human Bone Morphogenetic Protein 2 and Nano-Hydroxyapatite Adjacent to MG-63 Cell Line.

Authors:  Abdollah Ghorbanzadeh; Mohsen Aminsobhani; Ahad Khoshzaban; Armin Abbaszadeh; Behnam Bolhari; Atiyeh Ghorbanzadeh; Ahmad Reza Shamshiri
Journal:  J Dent (Tehran)       Date:  2015-05

4.  Porous Polyethylene Coated with Functionalized Hydroxyapatite Particles as a Bone Reconstruction Material.

Authors:  H Fouad; Randa AlFotawi; Othman Y Alothman; Basheer A Alshammari; Musaad Alfayez; Mohamed Hashem; Amer Mahmood
Journal:  Materials (Basel)       Date:  2018-03-29       Impact factor: 3.623

5.  A New Augmentation Method for Improved Screw Fixation in Fragile Bone.

Authors:  Deepak Bushan Raina; Vetra Markevičiūtė; Mindaugas Stravinskas; Joeri Kok; Ida Jacobson; Yang Liu; Erdem Aras Sezgin; Hanna Isaksson; Stefan Zwingenberger; Magnus Tägil; Šarūnas Tarasevičius; Lars Lidgren
Journal:  Front Bioeng Biotechnol       Date:  2022-03-02

6.  Assessment of cellular viability on calcium sulphate/hydroxyapatite injectable scaffolds.

Authors:  Randa Alfotawi; Kurt Naudi; Matthew J Dalby; K Elizabeth Tanner; Jeremy D McMahon; Ashraf Ayoub
Journal:  J Tissue Eng       Date:  2013-10-24       Impact factor: 7.813

7.  Development and characterization of an injectable cement of nano calcium-deficient hydroxyapatite/multi(amino acid) copolymer/calcium sulfate hemihydrate for bone repair.

Authors:  Xiaotong Qi; Hong Li; Bo Qiao; Weichao Li; Xinyan Hao; Jun Wu; Bao Su; Dianming Jiang
Journal:  Int J Nanomedicine       Date:  2013-11-21

8.  A Biphasic Calcium Sulphate/Hydroxyapatite Carrier Containing Bone Morphogenic Protein-2 and Zoledronic Acid Generates Bone.

Authors:  Deepak Bushan Raina; Hanna Isaksson; Werner Hettwer; Ashok Kumar; Lars Lidgren; Magnus Tägil
Journal:  Sci Rep       Date:  2016-05-18       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.